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Changes in the envelope proteins of retroviruses can alter the ability of these viruses to infect the central
nervous system (CNS) and induce neurological disease. In the present study, nine envelope residues were found
to influence neurovirulence of the Friend murine polytropic retrovirus Fr98. When projected on a threedimensional model, these residues were clustered in two spatially separated groups, one in variable region B
of the receptor binding site and the other on the opposite side of the envelope. Further studies indicated a role
for these residues in virus replication in the CNS, although the residues did not affect viral entry.
study, we analyzed which amino acids encoded by the SE
fragment of the Fr98 envelope gene were necessary or sufficient for the induction of neurological disease.
A common restriction site, BbsI, found in the 5⬘ end of the
envelope gene for both Fr54 and SE was used to generate a
chimeric virus, BE, that coded for Fr98 residues in the envelope region, but not in the polymerase gene. Newborn inbred
Rocky Mountain White (IRW) mice injected with BE by intraperitoneal inoculation developed clinical signs of ataxia
and/or seizures at 20 to 50 days postinoculation (Fig. 1A),
similar to that of mice injected with SE (17). Thus, the neurovirulent determinants of SE were encoded within the BE region of the envelope gene.
The envelope region encoded by BE contains most of the
receptor binding domain. The RBDs of type C retroviruses
share regions of homology interspersed with three variable
regions (variable regions A, B, and C [VRA, VRB, and VRC,
respectively]), which are believed to influence receptor specificity (2). Because of the strong sequence homology between
Friend murine leukemia virus (MLV) and Fr98 outside the
variable regions, we were able to predict the locations of the
VRA, VRB, and VRC regions in the Fr98 amino acid sequence (Fig. 2) as well as the putative three-dimensional structure of the Fr98 RBD based on the crystal structure of Friend
MLV (Fig. 3). Between the BbsI-EcoRI restriction sites, Fr98
and Fr54 encode 11 different residues: 2 in VRA, 1 in VRC, 5
in VRB, and 3 outside these variable regions (Fig. 2).
To begin to dissect the roles of these regions, using restriction mapping, we made two complementary viruses that carried genes encoding VRA/VRC or VRB regions of the Fr98.
Mice inoculated either with SA, which encoded the VRA/VRC
regions of Fr98, or with AE, which encoded the VRB region of
Fr98, had a low incidence of neurological disease compared to
mice infected with the BE virus (Fig. 1A). Thus, residues from
both regions were necessary for neurovirulence.

Amino acid sequence variations in retroviral envelope proteins play a critical role in altering viral pathogenesis and the
host response. Human immunodeficiency virus envelope variants vary in chemokine induction in vitro and may influence
neurovirulence in vivo (4, 18, 19). Similarly, simian immunodeficiency virus, feline immunodeficiency virus, and murine
retrovirus envelopes play a role in regulating virus infection,
host response, and neurological disease (1, 3, 8, 11, 15). Determining which amino acid residues are required for neurovirulence may provide important information on how retroviruses induce damage in the central nervous system (CNS).
The neurovirulence of the polytropic murine retrovirus Fr98
is encoded within the SphI-ClaI restriction sites of the viral
genome, which contain the 3⬘ end of the polymerase and most
of the viral envelope gene (16). The polytropic Fr54, which
differs from Fr98 by multiple nucleotide substitutions in the
SphI-ClaI region, does not induce neurovirulence, despite neuroinvasion and infection of similar brain cell types (16). Two
separate areas of the SphI-ClaI region influence neurovirulence, one region within the SphI-EcoRI (SE) restriction sites
and one within the EcoRI-ClaI (EC) restriction sites (6). These
regions mediate pathogenesis by separate mechanisms, as viruses encoding only the SE or EC region of the Fr98 genome
induce disease more slowly than Fr98 does (6).
Previous studies mapped the residues in the EC region responsible for neurovirulence to two residues at positions 165
and 168 (17) in the receptor binding domain (RBD) (5). However, the Fr98 residues in the SE region which are associated
with neurovirulence have not been identified. In the present
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To delineate which combination of envelope amino acids
encoded by BE contributed to disease, we created chimeric
viruses with sequential changes in this region using site-directed mutagenesis of the SphI-to-ClaI fragment of the BE or
AE viruses (Fig. 1B to D). Confirmation of the correct sequence was completed using sequencing prior to insertion of
the mutated SphI-ClaI region into the parent virus (16, 21).

The chimeric viruses BE-1 and BE-2 induced clinical disease at
a similar incidence as BE virus did, indicating that Fr98 residues at positions 16, 71, 72, and 84 were not necessary for
neurovirulence (Fig. 1B). Further analysis of the E and P
residues at positions 109 and 113 indicated that the P residue
at position 113 was important for neurovirulence, but the E
residue at position 109 was not (Fig. 1B).

FIG. 2. Alignment of amino acid sequence of SU (gp70) envelope proteins of Fr98 and Fr54 for the receptor binding domain. Residues 1 to
200 are shown, and the locations of BbsI, AflII, and EcoRI restriction sites are indicated. Residue 1 is the first residue in the mature gp70 SU
protein after cleavage of the signal peptide. The positions of variable regions VRA, VRB, and VRC are shown (2). Residues encoded between
BbsI and EcoRI that differed in Fr98 and Fr54 are in bold type. Boxed residues are those shown to influence neurovirulence in this paper. Boxed
residues 165 and 168 in white type on a black background were identified as important for neurovirulence in a previous paper (17).

Downloaded from http://jvi.asm.org/ on September 18, 2013 by UNIV OF MONTANA

FIG. 1. Survival curve analyses of mice inoculated with viral clones. (A to D) Mice were inoculated with viral clones BE (n ⫽ 24), AE (n ⫽
12), and SA (n ⫽ 8) (A), BE-1 (n ⫽ 4), BE-2 (n ⫽ 31), BE-3 (n ⫽ 12), and BE-4 (n ⫽ 11) (B), BE-5 (n ⫽ 10) and BE-6 (n ⫽ 24) (C), and BE-7
(n ⫽ 11) and BE-8 (n ⫽ 55) (D). IRW mice were infected with 104 focus-forming units of virus within 24 h of birth by intraperitoneal inoculation.
Mice were monitored for clinical signs of severe ataxia and seizures. Variant residues encoded between BbsI and EcoRI are shown for all viruses.
The amino acid residues encoded by BE (white letters on a black background) and the amino acid residues encoded by Fr54 (black letters on a
white background) are indicated. The numbers indicate the amino acid residue positions in the gp70 SU protein.
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The five variant residues in the VRB region were also tested
for their influence on disease. Two mutant viruses, BE-5 and
BE-6, with genes that encoded opposing Fr98 residues in the
VRB region induced only minimal disease (Fig. 1C). Thus,
both of these groups of residues in the VRB region contained
at least one amino acid involved in neurovirulence. These VRB
residues probably have receptor-specific interactions and are
likely to influence neurovirulence in this process.
Although the results of the above studies indicated that
residue 113 was critical for neurovirulence, the results of testing two additional mutant viruses suggested that this effect
could be modulated in the presence of additional Fr98 residues
at upstream positions. For example, BE-7 was highly virulent
despite having the Fr54 residues at positions 109 and 113 (Fig.
1D). However, this virulence was reduced by substitution of
the Fr54 residue at position 84 in mutant clone BE-8. Thus, the
presence of the Fr98 residue at either position 84 or 113
appeared to be sufficient for neurovirulence in the context of
these clones.
Previous studies indicated that virulence of the SE virus
correlated with high virus levels in the CNS and infection of
microglial cells (20). Therefore, we analyzed the kinetics of
virus infection of two high-neurovirulence (BE-1 and BE-2)
and two low-neurovirulence (BE-6 and BE-8) mutant viruses
in the brain using real-time reverse transcriptase PCR as previously described (9). Viral RNA was readily detected in the
brain in all virus-infected mice by 7 days postinfection (dpi),
with expression increasing approximately 10-fold by 14 dpi and
remaining high at 28 dpi (Fig. 4A). Interestingly, viral RNA
levels were higher in brain tissue from BE-1- and BE-2-infected mice than in brain tissue from BE-6- or BE-8-infected
mice at all three time points. Thus, the BE neurovirulent
amino acid residues were associated with increased virus levels
in the CNS. In contrast, splenic levels of viral RNA were
similar for all four viruses (Fig. 4B).
The difference in virus levels between neurovirulent and
nonneurovirulent mutant viruses may be due to the ability of
the virus to infect cells in the CNS. Therefore, we tested viral
entry of several mutant viral clones using a biochemical entry
assay (24) using primary cells prepared from cortical tissue
from 1- or 2-day-old IRW mice. There was no consistent correlation between virus entry and neurovirulence (Fig. 3C),
indicating that the residues did not influence neurovirulence by
affecting viral entry in primary cortical cells, which were mostly
astroglia, microglia, and fibroblasts.
Previous studies identified two residues at positions 165 and
168 in the EcoRI-ClaI region of the Fr98 envelope that contributed to neurovirulence (17). In the present study, we identified seven virulent residues in the BbsI-EcoRI region of the
Fr98 envelope (Fig. 1). Of the nine Fr98 residues that influence neurovirulence, one residue at position 84 is in VRC, five
residues are in VRB, and three residues are not located in any
variable region. In the predicted crystal structure model of

external surface. Because VRA and VRB sequences vary extensively
between Fr-MLV and Fr98, it is likely that the details of this portion
of the RBD model, such as the two helices and loop structures, are not
accurate for Fr98.
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FIG. 3. Three-dimensional representation of the crystal structure
of the RBD of Friend ecotropic murine leukemia virus (Fr-MLV) (5).
The crystal structure of the RBD of Fr-MLV (5) was obtained from
GenBank (Structure: accession number 1AOL) and visualized with the
Cn3D 4.1 program. The RBDs of Fr98 and Fr-MLV are highly homologous except at the variable regions (VRA, VRB, and VRC), and
this allowed modeling of the locations of variant Fr98 residues important for neurovirulence in this three-dimensional structure. Virulenceassociated residues in VRB are on the upper left part of the molecule,
whereas residues 84, 113, 165, and 168 are opposite on the lower right
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Fr98 (Fig. 3), these residues group into two different clusters,
one in VRB and the other encompassing VRC residue 84 plus
the nonvariable region residues at positions 113, 165, and 168.
Together this latter cluster of residues appears to form a
pocket on the surface of the RBD some distance away from the
VRB cluster (Fig. 3A, B, and C). BE neurovirulence requires
residues in both of these clusters on both sides of the envelope,
whereas EC neurovirulence requires residues only in the second cluster region and does not require specific Fr98 residues
in VRB (17). This correlates with distinct mechanisms of
pathogenesis for BE and EC (14).
One of the primary associations with neurovirulence of the
BE envelope was virus load in the CNS. Interestingly, viruses
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with altered residues either in VRB (BE-6) or in the second
pocket (BE-8) had reduced replication in the CNS compared
to viruses with the correct residues in both regions (Fig. 4A).
The residues in VRB may interact directly with the polytropic
receptor (xenotropic/polytropic receptor 1), perhaps affecting
receptor binding. The location of these residues on the other
side of the envelope protein may influence virus replication by
other mechanisms, perhaps influencing trimerization of the
envelope protein or interactions with other cellular proteins.
The influence of envelope amino acid residues on neuropathogenesis is a common finding for MuLVs. Point mutations
in the virus envelope protein influence the neurovirulence of
the ecotropic MuLV Ts1, which induces spongiform degeneration, and the ecotropic MuLV TR1.3, which induces intracerebral hemorrhage and stroke (7, 10, 12, 13, 22, 23). In contrast
to Ts1 and TR1.3 infection, Fr98 or BE infection of the CNS
induces only minimal pathological changes, despite the severe
clinical symptoms making it difficult to determine the downstream effects of these mutations. The amino acid residues
associated with BE neurovirulence appear to alter virus spread
in the brain, although they do not alter the ability of virus to
enter cells or infect other tissues, such as the spleen (Fig. 4).
The early differences in viral RNA levels at 7 and 14 dpi
suggest that the influence of these residues on virus load in the
CNS may be related to variation in transport from the spleen
to the brain as well as in neuroinvasion and infection of endothelia and microglia.
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Gary Hettrick for graphics assistance, and Kim Hasenkrug and John
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FIG. 4. Influence of residues on virus replication. (A and B) Brain
(A) and spleen (B) tissue from mock- or virus-infected mice were
removed at the indicated time points (7, 14, and 21 days postinfection)
and processed for gag RNA analysis. Real-time reverse transcriptase
PCR was used to analyze the expression of individual genes. Data are
calculated as gene expression relative to glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) expression per sample (as a percentage of
Gapdh expression). Data are the means ⫾ standard errors (error bars)
for three mice per group per time point. Statistical analysis was completed by two-way analysis of variance. Values that were significantly
different between virulent and nonvirulent viruses are indicated as
follows: ***, P ⬍ 0.001. (C) Viruses with different degrees of neurovirulence were analyzed for their ability to enter cells. Primary mixed
cortical cells were cultured with ⬃105 focus-forming units of each virus
for 16 h. DNA was then purified from each sample and analyzed for
viral DNA by real-time PCR analysis. Virus gag DNA levels were
calculated as a percentage of cellular Gapdh DNA levels to control for
the input of DNA. Heat-inactivated samples were used as a negative
control. Samples were analyzed in triplicate wells. Data are shown as
individual samples with error bars for each virus. Black symbols represent highly neurovirulent viruses, and gray symbols represent lowvirulence viruses.
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